CK Life Sciences (Holdings) (HKG:0775) reported a loss attributable to shareholders of HK$150.8 million for the six months ended June 30, compared with a profit of HK$1.0 million in the same period last year, according to a Tuesday Hong Kong bourse filing.

Basic loss per share was HK$0.0157, compared with earnings per share of HK$0.0001 a year earlier.

Revenue declined slightly to HK$2.61 billion from HK$2.64 billion in the prior year period.

The board did not declare an interim dividend for the period.